Cullinan Oncology (NASDAQ: CGEM)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Cullinan Oncology (NASDAQ: CGEM) through any online brokerage.
Other companies in Cullinan Oncology’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Kezar Life Sciences (NASDAQ:KZR), Altimmune (NASDAQ:ALT) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Cullinan Oncology (NASDAQ: CGEM) was reported by Deutsche Bank on Friday, August 12, 2022. The analyst firm set a price target for 212.00 expecting CGEM to rise to within 12 months (a possible 1482.09% upside). 50 analyst firms have reported ratings in the last year.
The stock price for Cullinan Oncology (NASDAQ: CGEM) is $13.4 last updated Today at August 12, 2022, 2:28 PM UTC.
The next Cullinan Oncology (CGEM) dividend date is projected to be Thursday, September 29, 2022.
Cullinan Oncology’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Cullinan Oncology.
Cullinan Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.